A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...

The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the ...

Three Husker students under the mentorship of Luwen Zhang, a leading University of Nebraska-Lincoln virologist, have achieved ...

skin immunology and renal pathology. Our methodologies range from in vitro approaches; in vivo modelling of inflammation and autoimmunity; clinical trials and systems biology. Clinically we have ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

A 2022 study found that just over 27% of people with systemic lupus erythematosus experience hearing loss, with 80% of cases being sensorineural hearing loss. This type of hearing loss usually ...

A new study sought to identify the frequency and determinants of flares for with people with systemic lupus erythematosus (SLE) with persistently active disease (PAD). Researchers found that both ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...